Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2020 Apr 22;117(18):10067–10078. doi: 10.1073/pnas.1916641117

Single-cell O2 exchange imaging shows that cytoplasmic diffusion is a dominant barrier to efficient gas transport in red blood cells

Sarah L Richardson a, Alzbeta Hulikova a, Melanie Proven b, Ria Hipkiss b, Magbor Akanni c, Noémi B A Roy b,d, Pawel Swietach a,1
PMCID: PMC7211990  PMID: 32321831

Significance

Blood is routinely tested for gas-carrying capacity (total hemoglobin), but this cannot determine the speed at which red blood cells (RBCs) exchange gases. Such information is critical for evaluating the physiological fitness of RBCs, which have very limited capillary transit times (<1 s) for turning over substantial volumes of gas. We developed a method to quantify gas exchange in individual RBCs and used it to show that restricted diffusion, imposed by hemoglobin crowding, is a major barrier to gas flows. Consequently, hematological disorders manifesting a change in cell shape or hemoglobin concentration have uncharted implications on gas exchange, which we illustrate using inherited anemias. With its single-cell resolution, the method can identify physiologically inferior subpopulations, providing a clinically useful appraisal of blood quality.

Keywords: erythrocyte, diffusion, oxygen, fluorescence, gas channels

Abstract

Disorders of oxygen transport are commonly attributed to inadequate carrying capacity (anemia) but may also relate to inefficient gas exchange by red blood cells (RBCs), a process that is poorly characterized yet assumed to be rapid. Without direct measurements of gas exchange at the single-cell level, the barriers to O2 transport and their relationship with hematological disorders remain ill defined. We developed a method to track the flow of O2 in individual RBCs by combining ultrarapid solution switching (to manipulate gas tension) with single-cell O2 saturation fluorescence microscopy. O2 unloading from RBCs was considerably slower than previously estimated in acellular hemoglobin solutions, indicating the presence of diffusional barriers in intact cells. Rate-limiting diffusion across cytoplasm was demonstrated by osmotically induced changes to hemoglobin concentration (i.e., diffusive tortuosity) and cell size (i.e., diffusion pathlength) and by comparing wild-type cells with hemoglobin H (HbH) thalassemia (shorter pathlength and reduced tortuosity) and hereditary spherocytosis (HS; expanded pathlength). Analysis of the distribution of O2 unloading rates in HS RBCs identified a subpopulation of spherocytes with greatly impaired gas exchange. Tortuosity imposed by hemoglobin was verified by demonstrating restricted diffusivity of CO2, an acidic gas, from the dissipative spread of photolytically uncaged H+ ions across cytoplasm. Our findings indicate that cytoplasmic diffusion, determined by pathlength and tortuosity, is a major barrier to efficient gas handling by RBCs. Consequently, changes in RBC shape and hemoglobin concentration, which are common manifestations of hematological disorders, can have hitherto unrecognized and clinically significant implications on gas exchange.


Red blood cells (RBCs) are highly adapted morphologically, biochemically, and physiologically to exchange large volumes of O2 and CO2 during a capillary sojourn of less than 1 s (1). Impairment to any one of these adaptations can compromise gas exchange at the lungs and systemic tissues to the detriment of whole-body physiology. Blood samples taken as part of clinical care are routinely tested for indices of O2-carrying capacity, such as total hemoglobin (Hb) concentration, hematocrit, or mean corpuscular hemoglobin concentration (MCHC), but these do not supply information pertaining to the kinetics of gas turnover. Indeed, impaired gas (un-)loading from RBCs can be as damaging as anemia but come undetected using routinely used blood tests.

Historically, our understanding of O2 handling by RBCs has been based on reaction rates measured in acellular Hb solutions. However, the intact RBC imposes additional structural barriers, such as membrane permeation and cytoplasmic diffusion (2). Due to their naturally rapid pace, gas fluxes in and out of RBCs are technically challenging to capture, and consequently, the rate-limiting steps for gas exchange are difficult to identify. In particular, measurements of gas diffusion inside intact RBCs are lacking, although it is widely assumed that this is a rapid process (37). In contrast, permeation across the membrane bilayer has been postulated to be rate limiting for gas flows (2), and a parallel pathway in the form of gas channels (8) is considered necessary for efficient gas exchange (913). If, contrary to this paradigm, resistance to gas flow was imposed mainly by the cytoplasm, then gas exchange would be exquisitely sensitive to cell shape (diffusion pathlength) and MCHC (tortuosity imposed by Hb “crowding”) (14, 15), with major implications for our understanding of RBC disorders. A comprehensive appraisal of gas handling must also consider RBC heterogeneity because many hematological disorders manifest a spectrum of phenotypes among circulating cells. Pooled population measurements of gas exchange inherently lack single-cell resolution and hence fail to detect subpopulations, which may be relevant to the management of blood diseases. Indeed, the clinical value of measuring the statistical distribution of an RBC parameter has been demonstrated for corpuscular volume, which has a wider distribution width in iron deficiency and certain thalassemias (16, 17).

For the purpose of this study, we developed a method for tracking gas exchange in RBCs at single-cell resolution. We apply this method to measure O2 (un-)loading in individual RBCs, describe the statistical distribution of gas exchange kinetics in a population of RBCs, and characterize the barriers that restrict the flow of respiratory gases. We tested evidence for rate-limiting diffusion by subjecting wild-type RBCs to osmotically induced changes in cell volume and Hb concentration and by studying RBC disorders in which diffusive properties are altered. Hemoglobin H (HbH) disease is an alpha-thalassemia commonly arising from the deletion of three alpha genes. It is characterized by microcytic and hypochromic RBCs (18), circumstances that would favor faster cytoplasmic diffusion rates, but also increased membrane rigidity (19), which should restrict membrane permeability (20). Hereditary spherocytosis (HS) is the most common inherited anemia with a prevalence of 1:2,000 in northern Europeans (21, 22). Here, defective surface anchoring of the cytoskeleton causes cells to progressively attain a spherical shape with expanded cytoplasmic pathlength for diffusing gases (21, 23). We illustrate the utility of making single-cell measurements by describing the kinetic heterogeneity of RBCs in HS blood. As the spleen extracts aberrantly shaped cells, blood from HS patients will contain a mixture of spherical and disk-shaped cells (24, 25). Although the physical characteristics of these subpopulations are known, their gas exchange kinetics are implicitly assumed to be adequate. This supposition underpins the rationale for interventions, such as splenectomy, which reverses anemia by withholding spherocytes. If, however, these “rescued” cells were found to be physiologically inadequate for exchanging O2, their systemic retention may be less beneficial than anticipated.

Herein, we present a single-cell method for tracking gas handling by RBCs and demonstrate its scientific and clinical value by describing the rate-limiting steps to efficient gas exchange and relating these to hematological disorders.

Results

O2 Exchange Can Be Followed in an Individual RBC by Single-Cell O2 Saturation Imaging.

The appropriate technique for measuring O2 handling by RBCs must satisfy two criteria: 1) produce rapid and well-controlled changes in O2 tension immediately outside the RBCs so that the maneuver itself does not artifactually set the rate of the biological response and 2) dynamically track the O2 saturation response in an individual RBC.

To address the first requirement, a double-barreled, square-bore (0.4-mm) microperfusion device (Fig. 1A) was used to rapidly alternate between an oxygenated microstream (bubbled with 100% O2) and a deoxygenated (anoxic) microstream (bubbled with 100% N2 and containing the O2 scavenger dithionite; 1 mM). Experiments were performed in the absence of CO2 to simplify data interpretation. To determine the speed of solution switching, the deoxygenated solution was labeled with 30 µM fluorescein (excitation 488 nm, emission 500 to 550 nm), and the device was placed upstream to RBCs that had been preloaded with CellTracker Deep-Red and settled at the base of a glass coverslip. Switching to the fluorescein-labeled microstream produced a sharp increase in fluorescence immediately outside cells following a very fast time constant of 23 ms (Fig. 1B).

Fig. 1.

Fig. 1.

Measuring O2 exchange in RBCs using single-cell O2-saturating imaging. (A) Schematic of a dual microperfusion device loaded with oxygenated and deoxygenated solutions. Inset shows both microstreams released in parallel, one of which was labeled with 30 µM fluorescein. When flows are calibrated and balanced, microstreams become clearly separated. (B) Ultrarapid switching between the microstreams. Hypoxic microstream was labeled with 30 µM fluorescein. Rate of solution switching can be estimated from the fluorescence signal surrounding RBCs (wild type) loaded with CellTracker Deep-Red. Switching between solutions can be achieved with a time constant of 23 ms (Inset; n = 5). (C) Wild-type RBCs loaded with a mixture of Deep-Red and Green, showing fluorescence in oxygenated and deoxygenated microstreams. For these experiments, neither solution was fluorescently labeled. Grayscale ratio maps (Right) were calculated from these fluorescence maps (Left and Center). (D) On deoxygenation, Deep-Red fluorescence is reduced, whereas Green remains constant (wild-type RBCs; n = 356 cells). (E) Illustration of the method’s ability to resolve differences in O2 saturation. The field of view was split into oxygenated and deoxygenated halves by releasing both microstreams in parallel; only cells in the deoxygenated compartment showed a decrease in Deep-Red/Green ratio.

The second criterion was met by exploiting O2-dependent changes in the optical properties of Hb. Upon oxygenation, absorbance of Hb in the 650- to 700-nm range decreases relative to that in the 500- to 550-nm range. Thus, O2 saturation of an individual RBC could be interrogated using a combination of two fluorescent dyes that emit in these ranges. A suitable pair of dyes is CellTracker Deep-Red and CellTracker Green (Fig. 1C), which produce no significant bleed through when excited by 633- and 488-nm lasers simultaneously. RBCs, loaded with CellTracker Deep-Red and CellTracker Green, were plated on a glass coverslip at the base of an inspection chamber and superfused with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes)-buffered solution (3 mL/min). The dual microperfusion device, placed upstream of cells, delivered a Hepes-buffered microstream at ∼8 µL/s, producing a linear velocity of 50 mm/s at the outlet of the pipette. Such laminar flow produces a modest shear rate of ∼102 s−1 (velocity/height of the stream), which is below the level that normally leads to complex deformations (e.g., parachute or polylobe) of RBCs in the microcirculation (26, 27). O2 unloading was triggered by switching from the oxygenated to deoxygenated microstream. This maneuver reduced Deep-Red fluorescence to a greater degree than Green fluorescence (Fig. 1D), and therefore, the fluorescence ratio provides a dynamic readout of Hb O2 saturation. To illustrate the versatility of this method, the dual microperfusion device was configured to release both microstreams in parallel, which sharply divided RBCs in the field of view according to oxygenation status (Fig. 1E). In this protocol, the response of Deep-Red to anoxia relates to Hb O2 unloading rather than an unreported effect of O2 on the dye, as no change in fluorescence ratio was observed in cell lines that do not produce Hb (SI Appendix, Fig. S1).

O2 Unloading from Wild-Type RBCs Is Slower than Previously Estimated.

Fig. 2A shows an exemplar time course of O2 saturation measured in RBCs during controlled changes in extracellular O2 tension. The kinetics of O2 unloading can be expressed in terms of a time constant (τO2) calculated by best fitting to a monoexponential curve (Fig. 2B). Since these measurements are performed on a cell-by-cell basis, the statistical distribution of τO2 can be obtained for the imaged cohort (Fig. 2C). Time courses can also be analyzed in terms of the overall decrease in ratio, which relates to the amount of oxygen released (Fig. 2D). The rate of O2 unloading was ∼30% faster at 37 °C compared with room temperature (23 °C), a difference that is consistent with the thermodynamics diffusion phenomena (28). To determine the rate of O2 unloading from wild-type RBCs, measurements were undertaken on blood samples from four control individuals (Fig. 2E). To improve temporal resolution, these experiments were performed at 23 °C. Data were acquired from at least five fields of view and five independent dye loadings in order to collect adequate data for constructing frequency histograms of τO2. Mean τO2 was similar in all control samples (Fig. 2F), and the population variance of τO2 was relatively small. The overall decrease in fluorescence ratio upon deoxygenation was, on average, 39% and showed narrow variation (Fig. 2G).

Fig. 2.

Fig. 2.

Measuring O2 exchange with single-cell resolution in wild-type (WT) RBCs. (A) Time course of O2 saturation during a 30-s exposure to deoxygenated solution (averaged for 10 cells within a single field of view). (B) Detail of unloading kinetics superimposed on the time course of solution exchange (Fig. 1B). Red lines are best-fit monoexponential curves. (C) Frequency histogram of the time constant of O2 unloading (τO2) and (D) overall change of fluorescence ratio measured at either 23 °C or 37 °C. (E) Histogram of τO2 in WT RBCs from four donors (WT1 to WT4) determined at 23 °C. (F) Mean ± variance for τO2 and (G) overall fluorescence ratio response (n = 702, 738, 1,489, 751). Gray lines show means for WT1 to WT4. (H) Schematic of the diffusion–reaction system that describes O2 unloading from RBCs. (I) Graphical solution to the diffusion–reaction equation shows the combinations of effective O2 diffusivity (DeffO2) and Hb–O2 dissociation rate constant (kd) that fit τO2 data for WT RBCs (0.971 s). Inset shows the equation that defines DeffO2 in terms of membrane permeation (Pm,O2), mean diffusion distance (h), and cytoplasmic diffusivity (Dc,O2). Simulation for WT RBC: h = 0.885 µm (half-thickness of RBC). Considering the experimentally derived range of kd (20 to 100 s−1), DeffO2 is <70 µm2/s.

In wild-type RBCs, mean τO2 was 0.971 s, which is strikingly slow, particularly in relation to a typical capillary transit time. Indeed, previous measurements on acellular Hb solutions had determined O2 unloading to follow a substantially faster time constant of 20 to 100 ms at matching temperature (23 °C) (3, 29). This discrepancy can be explained by the presence of additional barriers that exist uniquely in the cellular context, notably diffusion through cytoplasm and permeation across the surface membrane. The resistance imposed collectively by these barriers can be quantified using a mathematical model describing O2 unloading in terms of reaction, diffusion, and permeation (Fig. 2H). Using kinetic data for Hb–O2 binding, it is thus possible to estimate the effective diffusion coefficient (DeffO2), which lumps membrane permeation (Pm,O2), cytoplasmic diffusion (Dc,O2), and mean diffusion distance (h) as follows:

(DO2eff)1=(Dc,O2)1+(h×Pm,O2)1. [1]

Unbinding of the first O2 molecule from oxyhemoglobin follows a rate constant (kd) of 20 to 30 s−1 (3, 29), but subsequent unbinding steps are faster due to cooperativity, resulting in an ensemble kd as fast as ∼100 s−1. A mathematical representation of the Hb–O2 reaction (30) (equations in SI Appendix) was implemented to derive the combinations of DeffO2 and kd that fit τO2 measurements. To solve this problem for τO2 = 0.971 s and kd > 20 s−1, DeffO2 was determined to be <70 µm2/s (Fig. 2I) (i.e., <5% of O2 diffusivity in water) (31).

Cytoplasmic Diffusion Is a Substantial Barrier to Cellular Gas Exchange.

Low DeffO2 could arise from a combination of slow membrane permeation (Pm,O2) and slow cytoplasmic diffusion (Dc,O2). For example, unhindered cytoplasmic diffusivity would indicate a membrane permeability less than ∼80 µm/s (Eq. 1), but if cytoplasmic diffusivity was restricted, Pm,O2 must be accordingly higher. To investigate the dominant barrier to gas flow, the diffusive properties of RBCs were manipulated experimentally by changing extracellular osmolarity (adding or removing NaCl) within a range that does not result in substantial hemolysis. An increase in osmolarity reduces mean corpuscular volume (MCV), concentrates Hb (MCHC), and constricts cell thickness calculated as the quotient of MCV to cell area (Fig. 3A). Cell area was calculated from the outline of CellTracker fluorescence in RBCs and calibrated using fluorescent beads. These beads were also used to calibrate flow cytometric measurements of MCV. If gas transport were meaningfully obstructed by cytoplasm, then τO2 would be highly sensitive to changes in MCHC and cell thickness (i.e., diffusive tortuosity and diffusion pathlength, respectively). Indeed, O2 unloading measured over a range of osmolarity (Fig. 3B) followed a biphasic relationship with a nadir (i.e., fastest exchange) near physiological osmolarity (Fig. 3C). Slower gas flows under hypoosmotic conditions are consistent with expanded pathlengths in swollen cells; in contrast, hyperosmotic conditions may obstruct O2 exchange by the increase in Hb density. The relationship in Fig. 3C predicts that a condition with modestly reduced MCHC and dilated pathlength should produce slower O2 exchange. This was confirmed in RBCs from donors with mild to moderate iron deficiency (SI Appendix, Fig. S2), where a change in MCHC and cell thickness (equivalent to a mild hypoosmotic swelling of wild-type cells) slowed O2 unloading by 12%. Notwithstanding these inferences about the role of cytoplasmic diffusion in setting the rate of O2 unloading, an effect of osmolarity on membrane permeability properties cannot be excluded. There are two major routes for O2 entry across membranes—the lipid bilayer and putative gas channels—and their responses to osmotic stretch were interrogated by studying solute fluxes known to be rate limited by membrane permeation.

Fig. 3.

Fig. 3.

Effect of osmotic manipulations on transport properties in wild-type (WT) RBCs. (A) Changes in osmolarity brought about by adding or removing superfusate NaCl affect MCV, MCHC, and cell height (ratio of MCV to cell area). Mean ± SEM. (B) Both hypo- and hyperosmotic conditions slow the process of O2 unloading, which is quantified in terms of time constant τO2. (C) Biphasic relationship between osmolarity and τO2, with a nadir at physiological osmolarity. Mean ± variance (n = 3,688, 1,002, 3,680, 1,609, 895, and 841 from WT3 and WT4). (D) Deep-Red/Green ratio response to reversible cell swelling triggered by aquaporin-mediated glycerol influx under constant tonicity (100 mM glycerol replacing 100 mM sucrose). Experiments were performed under hypo- (+65 mM NaCl) and hypertonic (+140 mM NaCl) conditions. (E) Time constant of fluorescence ratio changes in response to glycerol influx (Upper) and efflux (Lower). (F) Glycerol permeability increases under hypotonic conditions. Mean ± SEM (n = 511 and 1,030 from WT3 and WT4). Equilibrium MCVs were 79 fL in 140 mM NaCl + 100 mM sucrose, 86 fL in 140 mM NaCl + 100 mM glycerol, 123 fL in 65 mM NaCl + 100 mM sucrose, and 148 fL in 65 mM NaCl + 100 mM glycerol. (G) pHi imaged in cSNARF1-loaded RBCs during a protocol that measures permeability to acetic acid. Cells were rapidly exposed to Na-acetate (65 mM) in the presence of DIDS (250 µM) to block AE1 activity. The rate of pHi change is a readout of acetic acid entry, which was measured over a range of osmolarity. (H) Hypo- and hyperosmotic conditions modestly affect membrane permeability to acetic acid. (I) A decrease in osmolarity modestly increases the product of acetic acid permeability and SA. Mean ± SEM (n = 930, 1,658, 1,500 from WT3 and WT4). (J) pHi imaged in cSNARF1-loaded RBCs during a protocol that measures AE1 activity. Extracellular pH was rapidly dropped from 7.4 to 6.8, and the rate of pHi change provides a readout of Cl/OH exchange, which was probed over a range of osmolarity. (K) Hypo- and hyperosmotic conditions affect AE1 activity. (L) A decrease in osmolarity increases the product of AE1 activity coefficient and SA. Mean ± SEM (n = 426, 730, 662 from WT3 and WT4). *Significant difference to physiological osmolarity.

Since aquaporins are putative gas channels (8, 13), the first protocol measured glycerol permeability as a readout of aquaporin AQP3-mediated transport (32). Experimental maneuvers involved rapid switching between 100 mM sucrose and 100 mM glycerol, thereby maintaining a constant extracellular osmolarity (33) (Fig. 3D). These solutions also contained either 65 or 140 mM NaCl to vary overall osmolarity. Changes in cell volume evoked by glycerol fluxes were monitored from the Deep-Red/Green fluorescence ratio, which, at constant O2 tension, decreases upon cell swelling (Fig. 3E). The product of glycerol permeability and cell surface area (SA) was higher in hypotonically swollen RBCs (Fig. 3F), indicating that membrane stretch is likely to increase rather than restrict aquaporin conductance. The second protocol followed the entry of acetic acid across the lipid bilayer from the time course of intracellular pH (pHi). To block the activity of Anion Exchanger 1 (AE1), which could influence pHi, DIDS (4,4′-diisothiocyano-2,2′-stilbenedisulfonic acid; 250 µM) was added to solutions. Acetic acid was delivered to RBCs by rapid solution switching, and changes in pHi were imaged using the fluorescent dye cSNARF1 loaded into cells (Fig. 3G). The ratio of the overall pHi change (related to buffering capacity) (SI Appendix, Fig. S3) and its time constant is equal to permeability multiplied by the SA/MCV ratio (Fig. 3H). Scaling by volume provides an appraisal of the lipid bilayer’s conductance to acetic acid (equations in SI Appendix). The membrane was found to be more permeable to acetic acid in osmotically swollen cells (Fig. 3I). The third protocol measured the activity of AE1, the most abundant ion transporter in the RBC membrane and, potentially, another pathway for gas entry. AE1-mediated transport was interrogated in cSNARF1-loaded RBCs by measuring the pHi response to a rapid extracellular acidification, which triggers Cl/OH exchange (Fig. 3J). The membrane’s AE1 transport capacity (Fig. 3K and equations in SI Appendix) increased steeply with osmotic swelling (Fig. 3L). We thus show that bilayer permeability (to acetic acid), aquaporin conductance (to glycerol), and AE1 activity are increased with hypotonic swelling. This general activatory effect of stretch on membrane permeability strongly suggests that the slowing of O2 exchange in hypotonically swollen RBCs (Fig. 3C) was not related to a tightening of membrane permeability to gases. Instead, the likely explanation for slower O2 transport is slow diffusion across an expanded cytoplasmic pathlength.

Slow Cytoplasmic Gas Diffusivity Arises from the High Density of Hb.

To determine the extent to which cytoplasm restricts the flow of gas, a more precise quantification of intracellular diffusivity is necessary. This was obtained by measuring a diffusive process evoked within the cytoplasmic compartment. Conveniently, intracellular diffusion of CO2, an acidic gas, can be traced from spatial pHi dynamics using a method that exploits the chemical equilibrium between CO2, HCO3, and H+ (14). The principle underpinning this technique is that H+ ions are unable to diffuse freely in the highly buffered environment of RBC cytoplasm; instead, transport occurs solely aboard buffer molecules (i.e., facilitated diffusion). Consequently, a measured (apparent) H+ diffusion coefficient (DHapp) is a readout of the diffusive properties of cytoplasmic buffers (14) (i.e., Hb and CO2/HCO3) (SI Appendix, Fig. S3). Cytoplasmic CO2 diffusivity (Dc,CO2) could thus be calculated by comparing DHapp measurements in the presence and absence of CO2/HCO3 buffer (14, 28).

Cytoplasmic H+ diffusion was triggered by photolytically uncaging H+ ions in one region of an RBC from the donor 6-nitroveratraldehyde (NVA; 1 mM) (Fig. 4A). To ensure that DHapp measurements relate to physiological pHi, starting pHi was offset to an alkaline level by raising superfusate pH to 7.8. Under superfusion with CO2/HCO3-free (Hepes-buffered) solutions, cytoplasmic H+ transport is facilitated by Hb molecules. The diffusive spread of H+ ions imaged in the horizontal plane from cSNARF1 fluorescence was slow in wild-type RBCs (Fig. 4B). Superfusion with CO2/HCO3 introduces a parallel H+ shuttle into cytoplasm (Fig. 4C), and for these experiments, 12.5 µM DIDS was added to block membrane transport of HCO3 by AE1 and thus, render the RBC a “closed” compartment with respect to H+ ions. If the diffusive capacity of intracellular CO2/HCO3 was substantial, the addition of this buffer would have increased DHapp profoundly, but this was not observed (Fig. 4D). A previously described diffusion–reaction model for RBC H+ dynamics estimated Dc,CO2 to be 48.9 ± 6.1 µm2/s (14), indicating substantially restricted diffusion relative to diffusivity in water (2,500 µm2/s). This degree of cytoplasmic obstruction is sufficient to explain slow O2 unloading without having to implicate another barrier, such as the membrane (Eq. 1).

Fig. 4.

Fig. 4.

Measuring CO2 diffusivity in RBC cytoplasm. (A) Photolytic uncaging of H+ ions from NVA at one end of a wild-type (WT) RBC produces an acidic microdomain that dissipates diffusively across cytoplasm, facilitated by Hb and (if added) CO2/HCO3 buffer. (B) Measurements in the absence of CO2/HCO3; time course of pHi (black trace) in 10 equally spaced ROIs across the width of a WT RBC. Traces for ROIs 1, 4, and 7 are shown for clarity. Best fit (red) to diffusion model for deriving H+ diffusivity, DHapp. (C) Protocol performed under superfusion with CO2/HCO3. (D) Summary data from four WT samples (n = 226 WT cells). (E) Relationship between osmolarity (varied by adding or removing NaCl) and DHapp in WT RBCs (n = 30 to 50 per bar). (F) Summary data from HS blood and three samples of reduced MCHC: iron deficiency (IDA1), puryvate kinase deficiency (PKD1), and HbH thalassemia (HbH3). Mean ± SEM (n = 20 to 35). (G) Relationship between MCHC and cytoplasmic CO2 diffusivity calculated from DHapp measured in the presence and absence of CO2/HCO3.

In order for short cytoplasmic distances to become significant barriers to gas exchange, the molecular components of RBCs must adequately obstruct the movement of gas. A likely candidate for this barrier function is Hb, which makes up ∼95% of the cell’s dry weight (34). This hypothesis was tested in RBCs that had been osmotically diluted or concentrated. DHapp measured in the presence or absence of CO2/HCO3 increased at lower MCHC (Fig. 4E). Importantly, a more dilute macromolecular milieu allowed CO2/HCO3 to become more effective at facilitating H+ transport. Consistent with this observation, RBCs from patients with reduced MCHC (iron deficiency anemia, pyruvate kinase deficiency, HbH thalassemia) supported faster DHapp (Fig. 4F).

It is plausible that the cytoskeleton may further influence gas movement, and this was explored in HS RBCs, which carry mutations in cytoskeletal elements. Hb-dependent H+ shuttling in HS RBCs was twofold lower than in wild-type cells but only modestly increased upon adding CO2/HCO3. Dc,CO2 in these cells was found to be 52.5 ± 9.4 µm2/s, i.e., not significantly different from wild-type RBCs and indicating that the molecular remodeling in HS does not alter CO2 diffusivity. In summary, the relationship between Dc,CO2 and MCHC (plotted up to 360 g/L) shows that a “loosening” of Hb density allows greater diffusive freedom (Fig. 4G). Slower O2 unloading from osmotically swollen RBCs (Fig. 3C) must, therefore, be attributed to a lengthening of diffusive path to an extent that outweighs reduced crowding at dilute MCHC.

Mercury Reduces Cytoplasmic Diffusion.

In some previous studies (8, 35), responses of gas exchange to mercurial substances were interpreted as evidence for channel-dependent gas permeation on the basis that conduits, such as aquaporins, are inhibited when reacted with Hg2+ (36). In RBCs, DIDS-sensitive Rh protein has also been proposed to conduct gases (11, 13). To test for these pathways, RBCs were pretreated with 100 µM DIDS and 250 µM Hg2+ for 10 min and assayed for O2 unloading rate (SI Appendix, Fig. S4A). The time constant for O2 unloading increased by a factor of three to 2.77 ± 0.39 s (SI Appendix, Fig. S4 B and C). However, this treatment also led to an increase in MCV (SI Appendix, Fig. S4D) and diffusion pathlength (SI Appendix, Fig. S4E). Additionally, Hg2+/DIDS reduced Hb-mediated H+ diffusion by a factor of two and obstructed H+ diffusivity in the presence of CO2/HCO3 by a factor of three (SI Appendix, Fig. S4F). Taken together, the threefold slowing of O2 exchange in Hg2+/DIDS-treated RBCs can be explained by a more tortuous cytoplasmic environment for diffusion and an expanded pathlength without necessarily implicating changes to membrane properties.

O2 Unloading Rate Is Altered in Disorders of RBC Shape and Hb Concentration.

Data obtained from wild-type RBCs subjected to osmotic manipulations of cell thickness (diffusion pathlength) and MCHC (diffusive tortuosity) demonstrate that the cytoplasm imposes a barrier to gas transport. In these experiments, changes to MCHC and cell dimensions are constrained mechanistically (Fig. 5A). To investigate other combinations of these variables, blood samples were obtained from patients with hematological disorders. In HbH thalassemia, low MCV and low MCHC are both predicted to favor faster O2 unloading. In contrast, RBCs from HS or hereditary elliptocytosis (HE) patients tend to have expanded diffusion paths. O2 exchange was measured in blood samples from three HbH patients (HbH1, -2, -3), six HS patients (HS1, -4, -5, -6, -8, -9), and one HE patient. The HS cohort recruited to this study included mutations that produce defects in the membrane skeleton (SPTB; 15 to 30% of all HS cases) and those leading to a membrane-destabilizing effect (SLC4A1; 33% of all HS cases) (21, 23) (SI Appendix, Table S1). Exemplar traces from one HbH sample and one HS sample are shown in Fig. 5B.

Fig. 5.

Fig. 5.

Disorders of RBC shape, size, and Hb affect O2 unloading. (A) Relationship between MCHC and cell height (thickness) for wild-type (WT) RBCs under various conditions of osmolarity (gray line) compared with data for HbH thalassemia (red), HS (green), and HE (blue). (B) Exemplar time course of O2 unloading in HbH, HS, and WT RBCs. (Inset) Traces normalized. (C) Frequency distribution of O2 unloading time constant (τO2) for HbH blood. (D) Mean ± variance for τO2 and (E) overall fluorescence ratio response in HbH RBCs (n = 968, 654, 1,152). Gray lines show mean for WT1 to WT4. (F) Frequency distribution of τO2 for HS and HE blood. (G) Mean ± variance for τO2 and (H) overall fluorescence ratio response (n = 834 to 1,811) for samples obtained from anemic and compensated HS patients and the compensated HE patient. Gray lines show mean for WT1 to WT4. (I) Blood from patient HS1. Cells were loaded with Deep-Red and Green (to measure O2 saturation) and SYTO45 (to stain nucleic acids). Overlay of Deep-Red and SYTO45 fluorescence (excited at 633 and 458 nm, respectively). Cells with high SYTO45 fluorescence and O2-sensitive Deep-Red/Green ratio are identified as reticulocytes (arrows). Measurements of τO2 and cell area (in the horizontal plane) related to SYTO45 fluorescence. Mean ± SEM (n = 1,656, 52, 23, 12). Reticulocytes (Rets) manifest the fastest O2 unloading rates. * denotes significant difference to cells with lowest SYTO45 signal (P < 0.05). (J) Distribution of cell area measured in the horizontal plane for HS RBCs from all six patients studied gated by τO2. (K) Relationship between osmolarity and τO2 for HS blood. Mean ± variance (n = 1,811, 1,267, 980). (L) Relationship between cell half-height and τO2 for WT and HS matched for comparable MCHC. (M) Relationship between cell half-height and τO2 for HbH and WT RBCs that have been hypoosmotically swollen to match the hypochromia in HbH (NaCl reduced by 25 mM).

In HbH thalassemia, the time constant for O2 unloading was faster than in wild-type RBCs (Fig. 5 C and D), consistent with a looser macromolecular environment for O2 diffusion and shorter diffusion distance. The surface membrane of HbH RBCs is characterized by greater rigidity (19), which generally reduces the membrane permeability to small solutes (20). The 30% faster τO2 thus indicates that membrane permeation is unlikely to be rate limiting, supporting the notion that cytoplasmic diffusivity is a major determinant of gas exchange. Consistent with the reduction in MCHC, the overall fluorescence ratio change in HbH thalassemia was smaller than in wild-type cells (Fig. 5E).

O2 exchange in HS and HE RBCs was significantly slower than in wild-type cells (Fig. 5 F and G). Strikingly, the frequency distribution of τO2 in HS/HE RBCs was wider and asymmetrical (Fig. 5F), with a significant fraction of cells manifesting radically slow exchange. Slower τO2 in HS RBCs is unlikely to relate to a change in membrane transport capacity because this was comparable with wild-type cells when probed in terms of AE1 activity (SI Appendix, Fig. S5). Instead, the most convincing explanation for slower exchange is the dilated diffusion path due to spherical remodeling (+25% in HS) (SI Appendix, Table S1). Moreover, this is numerically consistent with the ∼50% slowing of mean τO2 (diffusion delay is proportional to the square of distance). It is noteworthy that samples from clinically anemic HS patients (mean blood [Hb] = 89 g/L) produced a narrower distribution of τO2 and a faster average compared with compensated patients (mean blood [Hb] = 142 g/L; P = 0.0006). In contrast to these marked differences in O2 unloading kinetics, the net change in fluorescence ratio was comparable across the cohort of HS patients (Fig. 5H), and compensated patients had only modestly higher MCHC (353 vs. 339 g/L; P = 0.1) (SI Appendix, Table S1). The difference between compensated and anemic HS blood could not be explained by the percentage of reticulocytes (7.8 vs. 10.3%; P = 0.49). Instead, the wider distribution of τO2 and shift toward a slower mean in the compensated state are likely related to a greater retention of slowly exchanging spherocytes. These cells may have been more prone to removal in anemic HS patients, explaining the reduction in hematocrit and milder impairment of O2 unloading.

Spherical remodeling in HS is a progressive process that first becomes evident in reticulocytes (37). Older RBCs will have a greater degree of spherical remodeling, predicting age-related changes in O2 unloading. The youngest circulating RBCs (i.e., reticulocytes) were identified by staining for nucleic acids using SYTO45, which emits fluorescence (480 nm) in a range that is spectrally resolvable from CellTracker Deep-Red, and its excitation wavelength (458 nm) does not excite CellTracker Green. Reticulocytes can be identified by a positive SYTO45 signal and O2-sensitive Deep-Red/Green ratio (the latter criterion excludes Hb-negative white blood cells) (SI Appendix, Fig. S6A). The extent of spherical remodeling can be estimated from cell area measured in the horizontal plane, which decreases as a cell bulges toward a sphere. Data for τO2 and cell area were plotted as a function of SYTO45 fluorescence (patient HS1) (Fig. 5I). Compared with mature RBCs, reticulocytes have the largest cell area, demonstrating that they had undergone the least spherical remodeling in circulation. In agreement with the diffusion model, τO2 was fastest in reticulocytes (Fig. 5I and SI Appendix, Fig. S6C). This relationship between diffusion pathlength and τO2 was also shown in second sample (HS6) (SI Appendix, Fig. S6D). To confirm that gas exchange is slower in more spherically remodeled cells, data pooled from all six HS samples were grouped according to τO2 and reanalyzed in terms of cell area. For this analysis, the τO2 cutoff was 1.6 s because a third of HS cells exchange more slowly than this threshold compared with only a small minority (∼2%) of wild-type RBCs. In agreement with the proposed model, cells with slower τO2 had undergone more substantive spherical remodeling (Fig. 5J).

Another consequence of spherical remodeling is that osmotic disturbances will affect cell size in all dimensions, whereas wild-type RBCs tend to increase primarily in thickness (Fig. 3A). Consequently, changes in diffusion pathlength are more pronounced in disk-shaped cells, which is why τO2 is slower under hypoosmotic condition, despite the concurrent dilution of MCHC (Fig. 3C). In the case of RBCs from compensated HS patients, mild hypoosmotic swelling hastened τO2 (Fig. 5K) without greatly affecting the width of the frequency histogram (SI Appendix, Fig. S7A). This acceleration of τO2 is explained by MCHC dilution outweighing the effect of a more muted change in pathlength. As expected, hyperosmotic shrinkage of HS cells further slowed gas exchange due to a greater tortuosity imposed by Hb crowding. The distinct responses of HS and wild-type RBCs to osmotic changes can be predicted mathematically (SI Appendix, Fig. S7B).

In summary, disorders involving a change in pathlength (cell size) and tortuosity (MCHC) can substantially influence gas exchange. The positive relationship between τO2 and diffusion pathlength is demonstrated by comparing cells of matching MCHC, such as wild-type and HS RBCs (Fig. 5L). A similar relationship can be mapped for HbH cells and osmotically swollen wild-type RBCs at empirically matched MCHC (25 mM reduction in [NaCl]) (Fig. 5M).

Physiological Consequences of Slow Diffusion on Gas Exchange Function.

Measurements of O2 unloading from isolated RBCs suggest that gas exchange in capillaries may not attain completion under certain circumstances, such as shortened transit with high perfusion rates. Furthermore, any disease-related amplification of diffusive barriers could render gas exchange inefficient even under normal perfusion. To explore the physiological significance of restricted gas diffusion, the measured index of kinetics (τO2) was converted to the time required to unload 95% of stored O2 (T95), a more intuitive reporting standard, which is related mathematically as T95 = −log(0.05) × τO2. To reflect the physicochemical setting of RBCs in situ, this parameter was corrected for temperature and the presence of CO2, which affects Hb–O2 binding affinity. To adjust for temperature, T95 is scaled by 0.774 as determined experimentally (Fig. 2B). To account for typical blood PCO2 (40 mmHg), Hb–O2 binding kinetics were corrected for modestly reduced O2 affinity, modeled to be a factor of 0.949 (30). A requirement of the O2 unloading protocol is that the imaged RBCs remain attached to a coverslip, restricting gas exchange to the solution-facing side of cells. Thus, an additional correction was implemented to account for exchange taking place across the entire surface in vivo. Making both sides of the RBC available for exchange has the effect of reducing pathlength by a factor of two (i.e., a fourfold reduction in time delay according to Fick’s law).

Fig. 6A compares the distribution of T95 for RBCs obtained from wild-type, HbH, anemic HS, and compensated HS patients. The corresponding cumulative frequency curves (Fig. 6B) show the proportion of cells able to unload >95% of O2 in a given window of time. During the typical transit time of 0.71 s under resting perfusion (38) in a 500-µm-long coronary capillary (39), essentially all HbH RBCs and a 93% majority of wild-type RBCs are expected to unload 95% of stored O2. The equivalent percentage among HS RBCs is ∼75% for anemic blood and as little as ∼44% for compensated blood, indicating significantly impaired gas exchange function. The statistical distribution of T95 among wild-type and HbH RBCs is adequately described by a single Gaussian (wild type: mean 0.51 s, variance 0.10 s; HbH: mean 0.36 s, variance 0.08 s). In contrast, T95 in HS RBCs is best fitted by the sum of two Gaussian curves, representing a faster population and a slower population (Fig. 6C). The fraction of cells in the slower subpopulation increased from 48% in anemic HS blood to 62% in compensated HS blood.

Fig. 6.

Fig. 6.

Physiological consequences of slow gas diffusion in RBC cytoplasm. (A) Frequency histogram of the time to unload 95% O2 (T95) from wild-type, HS, and HbH RBCs after correcting for temperature and CO2. (B) Cumulative frequency distribution. The dashed line denotes typical coronary capillary transit time. (C) Analysis of the frequency distribution with mixed Gaussian modeling for wild-type, HbH, anemic, and compensated HS RBCs. Note that, for HS blood, the best fit required two Gaussian curves (fast and slow subpopulations). (D) Mathematical simulation of the rate of O2 unloading from wild-type, HbH, and HS blood over a range of perfusion rates. (E) O2 unloading from HbH and HS blood relative to wild-type blood.

The physiological fitness of these RBC populations can be compared using a mathematical model of capillary flow that simulates the rate of O2 release as a function of blood perfusion (equations in SI Appendix). O2 delivery from wild-type blood reaches a plateau of ∼160 fmol/s when perfusion is an order of magnitude above resting. Both HbH and HS blood delivered O2 at an impaired rate (Fig. 6D). In the case of HbH thalassemia, O2 delivery was ∼35% reduced at low perfusion because of reduced blood [Hb], but as perfusion accelerates, the disadvantage relative to wild-type blood became less apparent (Fig. 6E). This partial recovery arises because HbH cells are faster at unloading O2 and during shorter transit times, can release a greater fraction of stored O2 compared with wild-type RBCs. This kinetic advantage partly offsets the effect of reduced MCHC. O2 delivery from anemic HS blood was also compromised (by ∼38%) due to low [Hb] and remained significantly disadvantaged at higher perfusion (Fig. 6 D and E). In compensated HS blood, the nominal recovery of hematocrit supported near-normal O2 delivery at low perfusion rates, but this progressively worsened at higher blood flows (Fig. 6 D and E). This perfusion-dependent impairment to O2 delivery can be attributed to the failure of the slower RBC subpopulation to release sufficient O2 during abbreviated capillary transit. The above modeling results illustrate that a full recovery of hematocrit does not necessarily predict a full recovery of O2 exchange function.

Discussion

Using single-cell approaches, we have shown that gas handling by RBCs is slower than previously described, which we attribute to a hitherto underestimated effect of restricted diffusion across RBC cytoplasm. To attain the necessary resolving power for tracking O2 exchange in an individual RBC, we developed a method that combines microfluidics (to manipulate gas tension) and ratiometric fluorescence imaging (to monitor the ensuing cellular response) (Fig. 1). A consequence of slow gas diffusion is impaired gas unloading at tissues, particularly during periods of increased perfusion, such as exercise (Fig. 6D). This finding has clinical implications because disorders of RBCs affecting shape, size, or Hb concentration will strongly influence overall gas exchange.

Our observations were made on RBCs superfused under modest shear rates (γ) of ∼102 s−1, which are representative of large vessels (e.g., aorta) (40, 41). In vivo, RBCs traveling through capillaries will deform to fit through the narrow lumen (42), at which point γ can reach 1,500 s−1 (27). With rising shear, RBCs first become cup-shaped stomatocytes (or parachutes) and above γ > 400 s−1, attain a polylobed shape (40). However, even at γ = 2,500 s−1, RBCs do not stretch substantially (43), meaning that their critical thickness remains a significant diffusional barrier, not dissimilar to that in discocytes. Early experimental designs based on highly viscous media (to increase γ) reported tank treading, which results in elliptically stretched (i.e., thinner) RBCs (44, 45). However, tank treading is not normally observed in media of physiological viscosity (27, 41, 46) or in narrow vessels at high γ (41). Although our method does not recapitulate the shear rates in capillaries, it stabilizes cell thickness at a level that is relevant to physiologically deformed cells for robust measurements of diffusional delays.

Our measurements of O2 unloading indicate that membrane permeation and cytoplasmic diffusion collectively reduce O2 diffusivity in wild-type RBCs to <70 µm2/s (i.e., a >35-fold decrease relative to plasma) (3, 29). Based on several independent lines of evidence, we show that the majority of this restriction is attributable to slow cytoplasmic diffusion rather than slow membrane permeation. We first show that CO2 diffuses at ∼50 µm2/s in the cytoplasmic compartment (Fig. 4D). To arrive at this value, we applied a previously published method (14) that probes the dissipation of cytoplasmic solute gradients at the subcellular level and therefore, is not sensitive to membrane properties. Given that O2 and CO2 have similar diffusive properties in plasma, a substantial resistance to gas transport must reside in the cytoplasm. Using osmotically diluted wild-type cells and RBCs from individuals of low MCHC, we show that this cytoplasmic barrier arises from macromolecular crowding because CO2 diffusivity halves with every 62-g/L rise in MCHC (Fig. 4G).

A separate line of evidence in favor of rate-setting cytoplasmic diffusion is the response of O2 unloading to changes in diffusion pathlength. Osmotic swelling of wild-type RBCs decreases the rate of O2 unloading (Fig. 3C), despite a concurrent dilution of Hb and a general increase in membrane permeability properties. The latter was probed by analyzing acetic acid entry across the lipid bilayer (Fig. 3I), aquaporin-mediated glycerol transport (Fig. 3F), and AE1-dependent Cl/OH exchange (Fig. 3L). Although the permeability of these solutes will be different to O2, these measurements provide readouts of how the distinct routes for gas entry (the lipid bilayer and gas channels) may respond to osmotic stretch. In all three cases, stretch increased conductance, which is also a likely response of O2 permeation. The overall slowing of gas exchange in hypotonically swollen RBCs must, therefore, relate to the expanded diffusion path in swollen cytoplasm. The importance of pathlength was also demonstrated in RBCs from HbH thalassemia and HS patients (Fig. 5). Compared with wild-type RBCs, O2 unloading from HbH cells was faster (Fig. 5 C and D), which our model can explain in terms of a shorter diffusion path acting in concert with lower MCHC (less tortuous cytoplasm). The argument for rate-setting cytoplasmic diffusion is strengthened by the observation that HbH cells also have higher Hb–O2 affinity (18) and a more rigid (19) [hence, less permeable (20)] surface membrane, two factors that would have reduced gas exchange kinetics, if rate limiting. HS blood contains RBCs manifesting a range of geometrical remodeling, and the most spherical cells (i.e., bearing the longest cytoplasmic pathlength) were found to exchange gases slower (Fig. 5J). In a sample of HS blood, O2 unloading was fastest in reticulocytes (i.e., the youngest RBCs in circulation) (Fig. 5I and SI Appendix, Fig. S6). Compared with mature RBCs, reticulocytes have modestly greater volume (+20%) (37), but the majority of this difference is transmitted to a growth in horizontal cell area (+40%) (Fig. 5I). Consequently, HS reticulocytes are thinner than mature RBCs, consistent with the notion that they had the least time in circulation to undergo spherical remodeling. Additionally, reticulocytes have modestly lower MCHC (−15%) (SI Appendix, Fig. S6B) (37), which also contributes toward faster gas exchange, in agreement with our proposed model. The prominence of the cytoplasmic barrier in setting gas exchange is illustrated by the Fickian relationship between diffusion distance and time delay plotted for cells at matching MCHC (Fig. 5 L and M).

Overall, our evidence is not supportive of rate-limiting membrane permeation. For instance, if the membrane was rate limiting for O2 unloading, then we would have expected faster rates in osmotically swollen wild-type RBCs (due to an activation of membrane permeability properties) (Fig. 3) and slower exchange in HbH cells [due to increased rigidity (19, 20)], but neither of these were observed. While we confirm that blockers of putative gas channels (Hg2+/DIDS) slow O2 unloading, we attribute this effect to an expansion of pathlength and further slowing of cytoplasmic diffusivity (SI Appendix, Fig. S4) rather than a change in membrane permeability. The sensitivity of gas transport to cell thickness highlights the importance of accounting for cell dimensions when interpreting measurements of gas handling in response to drugs or in disease models. Moreover, a cell membrane can be erroneously attributed a low permeability constant if it is adjacent to a high-resistance cytoplasmic barrier, but the measurement technique assumes fast diffusion in cytoplasm.

Given that our method for tracking O2 exchange has single-cell resolution, we have been able to describe populations of cells in terms of a tangible measure of RBC physiological fitness. Frequency histograms can readily identify subpopulations, which would otherwise be disguised in pooled population measurements. While wild-type and HbH RBCs are a relatively homogenous population, results from HS patients present evidence for a large subpopulation of spherocytes with significantly impaired gas exchange (Fig. 6C). This slow population was more evident in HS patients with compensated [Hb], which could not be explained in terms of the percentage of reticulocytes (SI Appendix, Table S1) or a change in the transport capacity of the membrane (probed in terms of AE1 activity) (SI Appendix, Fig. S5). Instead, the likely reason for the broader distribution of τO2 and shift toward a lower mean is that the compensated state arises from a retention of spherocytes with longer diffusion pathlengths. Thus, the recovery of hematocrit comes at the price of a slower population-averaged rate of O2 unloading. Since these spherical RBCs also have altered deformability (47), gas exchange may be further compromised at the high shear rates inside capillaries.

Findings described herein can influence clinical practice by providing information about the functional quality of blood, an assessment that is lacking in clinical trials and guidelines regarding treatments and procedures, such as splenectomy. Changes to gas transport in disorders of blood are largely interpreted in terms of hematocrit, and consequently, clinical guidelines for anemias generally prioritize interventions that increase RBC count (48), even if this inadvertently leads to a retention of physiologically inferior cells. However, a full recovery of hematocrit may not necessarily produce a proportional improvement in O2 delivery as this critically depends on the diffusion delays in cells that underpin the reversal of anemia. The rationale for splenectomy, for instance, is to improve anemia by systemically withholding RBCs from premature destruction. While splenectomy is generally advocated in transfusion-dependent HS [European Hematology Association (49)], the recommendations for moderate forms of the disease (two-thirds of patients) are less clear because of the lack of appropriate randomized trials (49, 50). While there is evidence that splenectomy can ameliorate anemia assayed in terms of O2 storage (total [Hb] or hematocrit) (5153), its effect on gas exchange kinetics is uncharted. Without such a functional assessment, it is not possible to determine whether a splenectomy is physiologically curative. This information would be important in cost–benefit analyses, where infection and thrombosis are major complications of splenectomy (48, 49). As an illustration of the inadequacy of current guidelines, half of children who underwent partial splenectomy were later found to require a full procedure to resolve symptoms (49). This observation may suggest that contemporary recommendations may overestimate the curative value of a partial splenectomy. Future guidelines could improve predictive power if based on prospective studies that factor the gain in the physiological quality of blood against the risks. Analysis of our nonsplenectomized patient cohort reveals a sizable proportion of RBCs unable to provide efficient gas delivery (Fig. 6B). Even in HS patients with nominally compensated [Hb] levels, O2 exchange kinetics remain below normal. A full restoration of O2 delivery rate would, therefore, require an overshoot of hematocrit, which may have unfavorable repercussions (e.g., increased blood viscosity) and possibly necessitate a more radical splenectomy. By monitoring the extent of anemia and obtaining the population-wide distribution of RBC quality, it would be possible to predict the extent to which a partial or complete splenectomy improves physiological outcomes. Such information may provide insights into the hitherto unexplained variability of HS patient responses to splenectomy (54).

In summary, we describe an approach for interrogating the physiological quality of RBCs. We use this to identify barriers to gas flow, characterize population-level heterogeneity in terms of gas exchange kinetics, and evaluate the functional consequences of hematological disorders with single-cell resolution. By providing a kinetic appraisal of blood quality, this method could be implemented in clinical trials that inform guidelines for the clinical management of hematological disorders. Similarly, it could perform quality control of blood for transfusion that is known to undergo spontaneous shape changes during storage (55). The notion of restricted gas diffusion in a protein-rich cytoplasmic matrix is likely to apply to cells other than RBCs. The genesis of tissue hypoxia, which evokes the virtually ubiquitous hypoxia-inducible factor (HIF)-dependent signaling cascade (56), is typically considered in terms of high metabolic O2 consumption, but our results indicate that slow O2 diffusion may be an additional biologically regulated variable to consider.

Materials and Methods

Patients and Ethical Approval.

Venous blood was obtained from healthy volunteers and from consenting patients with hematological disorders (HbH thalassemia, HS, HE, pyruvate kinase deficiency) attending the hematology clinic at Oxford University Hospitals (ethical approval REC 13WA0371). Samples were deidentified prior to use and then, referred to using an anonymized alphanumerical code. Blood parameters were determined by routine clinical methods (Sysmex XN series) and are listed in SI Appendix, Table S1. Cell volume was measured flow cytometrically and calibrated by standard procedures. Cell area was measured in CellTracker-labeled RBCs by fluorescence imaging in the horizontal plane during superfusion experiments. Area was calibrated by fluorescent beads (Beckman FluoroSphere) of known geometry (10 µm in diameter). Mean thickness of cells (also referred to as cell height) was calculated as the ratio of MCV to cell area.

Single-Cell O2 Saturation Imaging.

Blood was first diluted 200-fold in Ca2+-free Hepes-buffered Tyrode, and cells were loaded with a mixture of CellTracker Deep-Red (5 µM) and CellTracker Green (15 µM) in dimethyl sulfoxide (DMSO). For some experiments, cells were also loaded with SYTO45 (Invitrogen) at 1:1,000 dilution of 5 mM stock. After allowing 10 min for dye loading, cells were spun down, resuspended in Ca2+-containing solution, and plated on a poly-l-lysine pretreated Perspex superfusion chamber that was mounted on a Leica LCS confocal system. Cells were superfused with solutions at 23 °C or 37 °C. CellTracker Deep-Red and Green dyes were excited simultaneously by 488- and 633-nm laser lines, and fluorescence was acquired by two photomultiplier tubes at 500 to 550 and 650 to 700 nm at 7.8 Hz in bidirectional xy scan mode (128 × 128 pixels) to maximize temporal resolution with pinhole at 4 Airy units to maximize signal to background ratio. Fluorescence was ratioed and normalized to starting ratio.

Ultrarapid Solution Switching.

A dual microperfusion device (52) released one of two types of solution (57, 58). One microstream was fed from a reservoir bubbled with O2; the second microstream was fed from a reservoir containing 1 mM sodium dithionite and bubbled with N2 to produce anoxia. Under gravity feed, solution flows were first adjusted manually to produce equal velocity; this was visualized as a sharp interstream boundary when both solutions were running (57, 58). On average, flow per channel was 8 µL/s. At the outlet of the device (square bore of side 400 µm), the linear velocity was 50 mm/s, producing shear rates of 102 s−1. At this speed, solution exchange is rapid but does not produce visible deformation of cells as determined by symmetrical cell area and normal cell thickness. Before measurements, the device was flushed to clear stagnant solution, which may have become oxygenated prior to experiments. Following this, the device was placed upstream within a 200 × 200-µm field of view containing RBCs. After equilibration with the oxygenated microstream, O2 unloading was triggered by a 30-s exposure to the anoxic microstream.

Cytoplasmic pH Imaging and H+ Uncaging.

Blood was first diluted 200-fold in Ca2+-free Hepes-buffered Tyrode, and cells were loaded with the pH reporter cSNARF1 (acetoxymethyl ester; 20 µM). After allowing 10 min for loading, cells were plated on a poly-l-lysine pretreated Perspex superfusion chamber, which was mounted on a Zeiss LSM 700 confocal system. Cells were superfused with Ca2+-containing solutions heated to 37 °C. cSNARF1 was excited at 555 nm, and emission was collected at 580 and 640 nm by x–y mode scanning and pinhole at 6.3 Airy units. The fluorescence ratio was converted to pH using a previously determined calibration curve (59). To uncage H+ ions, 1 mM NVA was added to superfusates, and 405-nm laser light was guided to photolytically release H+ ions in a region of interest (ROI) at one end of an RBC (width equal to 1/10th of cell diameter). To produce a continuous source of localized acid loading, uncaging alternated with cSNARF1 imaging every 0.133 s.

Solutions.

Hepes-buffered solutions were 130 mM NaCl, 4.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 11 mM glucose, and 20 mM Hepes pH adjusted to 6.8, 7.4, or 7.8 with 4 M NaOH. CO2/HCO3-buffered solutions at pH 7.8 were 75 mM NaCl, 4.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 11 mM glucose, and 55 mM NaHCO3 bubbled with 5% CO2/balanced air. To change osmolarity, the amount of NaCl was varied, and final osmolarity was measured by freezing point depression (Camlab Osmometer). For osmolarities of 180, 209, 238, 267, 297, 326, 355, and 414 mOsm/kg, NaCl values in Hepes-buffered solutions were 65, 81.25, 97.5, 113.75, 130, 146.25, 162.5, and 195 mM. The concentration of NaCl was reduced accordingly in CO2/HCO3-buffered solutions (by 55 mM) or in acetate-containing solutions (by 65 mM). For Ca2+-free solution, 1 mM Ca2+ was replaced with 0.5 mM ethylene glycol bis(b-aminoethyl ether)-N,N,N′,N′-tetraacetic acid. All salts were obtained from Sigma-Aldrich.

Data Availability.

All relevant data are included herein or in SI Appendix. All relevant clinical information concerning patient samples is given in SI Appendix, Table S1.

Supplementary Material

Supplementary File

Acknowledgments

We thank Prof. Kenneth Spitzer for training and help in setting up the dual microperfusion equipment, Kyung Chan Park for collecting venous blood, Dr. Matthew Frise for access to blood samples, Rosie Brady for helpful comments on the manuscript, and Prof. Daniele Dini for performing calculations relating to shear rate. This work was supported by British Heart Foundation Programme Grant RG/15/9/31534 (to P.S.) and Corpus Christi College, Oxford.

Footnotes

The authors declare no competing interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1916641117/-/DCSupplemental.

References

  • 1.Wagner P. D., Diffusion and chemical reaction in pulmonary gas exchange. Physiol. Rev. 57, 257–312 (1977). [DOI] [PubMed] [Google Scholar]
  • 2.Boron W. F., Endeward V., Gros G., Musa-Aziz R., Pohl P., Intrinsic CO2 permeability of cell membranes and potential biological relevance of CO2 channels. ChemPhysChem 12, 1017–1019 (2011). [DOI] [PubMed] [Google Scholar]
  • 3.Chakraborty S., Balakotaiah V., Bidani A., Diffusing capacity reexamined: Relative roles of diffusion and chemical reaction in red cell uptake of O2, CO, CO2, and NO. J. Appl. Physiol. 97, 2284–2302 (2004). [DOI] [PubMed] [Google Scholar]
  • 4.Geers C., Gros G., Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol. Rev. 80, 681–715 (2000). [DOI] [PubMed] [Google Scholar]
  • 5.Gros G., Moll W., The diffusion of carbon dioxide in erythrocytes and hemoglobin solutions. Pflugers Arch. 324, 249–266 (1971). [DOI] [PubMed] [Google Scholar]
  • 6.Vandegriff K. D., Olson J. S., Morphological and physiological factors affecting oxygen uptake and release by red blood cells. J. Biol. Chem. 259, 12619–12627 (1984). [PubMed] [Google Scholar]
  • 7.Vandegriff K. D., Olson J. S., The kinetics of O2 release by human red blood cells in the presence of external sodium dithionite. J. Biol. Chem. 259, 12609–12618 (1984). [PubMed] [Google Scholar]
  • 8.Boron W. F., Sharpey-schafer lecture: Gas channels. Exp. Physiol. 95, 1107–1130 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Endeward V., Al-Samir S., Itel F., Gros G., How does carbon dioxide permeate cell membranes? A discussion of concepts, results and methods. Front. Physiol. 4, 382 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Endeward V., Cartron J. P., Ripoche P., Gros G., Red cell membrane CO2 permeability in normal human blood and in blood deficient in various blood groups, and effect of DIDS. Transfus. Clin. Biol. 13, 123–127 (2006). [DOI] [PubMed] [Google Scholar]
  • 11.Endeward V., Cartron J. P., Ripoche P., Gros G., RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane. FASEB J. 22, 64–73 (2008). [DOI] [PubMed] [Google Scholar]
  • 12.Endeward V., Gros G., Low carbon dioxide permeability of the apical epithelial membrane of Guinea-pig colon. J. Physiol. 567, 253–265 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Endeward V., et al. , Evidence that aquaporin 1 is a major pathway for CO2 transport across the human erythrocyte membrane. FASEB J. 20, 1974–1981 (2006). [DOI] [PubMed] [Google Scholar]
  • 14.Richardson S. L., Swietach P., Red blood cell thickness is evolutionarily constrained by slow, hemoglobin-restricted diffusion in cytoplasm. Sci. Rep. 6, 36018 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hannesschlaeger C., Horner A., Pohl P., Intrinsic membrane permeability to small molecules. Chem. Rev. 119, 5922–5953 (2019). [DOI] [PubMed] [Google Scholar]
  • 16.Aslan D., Gümrük F., Gürgey A., Altay C., Importance of RDW value in differential diagnosis of hypochrome anemias. Am. J. Hematol. 69, 31–33 (2002). [DOI] [PubMed] [Google Scholar]
  • 17.Bouri S., Martin J., Investigation of iron deficiency anaemia. Clin. Med. 18, 242–244 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Galanello R., Cao A., Gene test review. Alpha-thalassemia. Genet. Med. 13, 83–88 (2011). [DOI] [PubMed] [Google Scholar]
  • 19.Schrier S. L., Rachmilewitz E., Mohandas N., Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: Implication for differences in clinical manifestations. Blood 74, 2194–2202 (1989). [PubMed] [Google Scholar]
  • 20.Lande M. B., Donovan J. M., Zeidel M. L., The relationship between membrane fluidity and permeabilities to water, solutes, ammonia, and protons. J. Gen. Physiol. 106, 67–84 (1995). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Perrotta S., Gallagher P. G., Mohandas N., Hereditary spherocytosis. Lancet 372, 1411–1426 (2008). [DOI] [PubMed] [Google Scholar]
  • 22.Delaunay J., The molecular basis of hereditary red cell membrane disorders. Blood Rev. 21, 1–20 (2007). [DOI] [PubMed] [Google Scholar]
  • 23.Eber S., Lux S. E., Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin. Hematol. 41, 118–141 (2004). [DOI] [PubMed] [Google Scholar]
  • 24.Michaels L. A., Cohen A. R., Zhao H., Raphael R. I., Manno C. S., Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J. Pediatr. 130, 957–960 (1997). [DOI] [PubMed] [Google Scholar]
  • 25.Kutter D., Coulon N., Stirn F., Thoma M., Janecki J., Demonstration and quantification of “hyperchromic” erythrocytes by haematological analysers. Application to screening for hereditary and acquired spherocytosis. Clin. Lab. 48, 163–170 (2002). [PubMed] [Google Scholar]
  • 26.Connes P., et al. , The role of blood rheology in sickle cell disease. Blood Rev. 30, 111–118 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nader E., et al. , Blood rheology: Key parameters, impact on blood flow, role in sickle cell disease and effects of exercise. Front. Physiol. 10, 1329 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Swietach P., et al. , Modelling intracellular H(+) ion diffusion. Prog. Biophys. Mol. Biol. 83, 69–100 (2003). [DOI] [PubMed] [Google Scholar]
  • 29.Olson J. S., Foley E. W., Maillett D. H., Paster E. V., “Measurement of rate constants for reactions of O2, CO, and NO with hemoglobin” in Hemoglobin Disorders: Methods in Molecular Biology, Nagel R. L., Ed. (Humana Press, Totowa, NJ, 2003), vol. 82, p. 65–91. [DOI] [PubMed] [Google Scholar]
  • 30.Dash R. K., Korman B., Bassingthwaighte J. B., Simple accurate mathematical models of blood HbO2 and HbCO2 dissociation curves at varied physiological conditions: Evaluation and comparison with other models. Eur. J. Appl. Physiol. 116, 97–113 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Han P., Bartels D. M., Temperature dependence of oxygen diffusion in H2O and D2O. J. Phys. Chem. 100, 5597–5602 (1996). [Google Scholar]
  • 32.Roudier N., Verbavatz J. M., Maurel C., Ripoche P., Tacnet F., Evidence for the presence of aquaporin-3 in human red blood cells. J. Biol. Chem. 273, 8407–8412 (1998). [DOI] [PubMed] [Google Scholar]
  • 33.Madeira A., Moura T. F., Soveral G., Detecting aquaporin function and regulation. Front Chem. 4, 3 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Longeville S., Stingaciu L. R., Hemoglobin diffusion and the dynamics of oxygen capture by red blood cells. Sci. Rep. 7, 10448 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cooper G. J., Boron W. F., Effect of PCMBS on CO2 permeability of Xenopus oocytes expressing aquaporin 1 or its C189S mutant. Am. J. Physiol. 275, C1481–C1486 (1998). [DOI] [PubMed] [Google Scholar]
  • 36.Virkki L. V., Franke C., Somieski P., Boron W. F., Cloning and functional characterization of a novel aquaporin from Xenopus laevis oocytes. J. Biol. Chem. 277, 40610–40616 (2002). [DOI] [PubMed] [Google Scholar]
  • 37.Da Costa L., et al. , Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood 98, 2894–2899 (2001). [DOI] [PubMed] [Google Scholar]
  • 38.Allard M. F., Kamimura C. T., English D. R., Henning S. L., Wiggs B. R., Regional myocardial capillary erythrocyte transit time in the normal resting heart. Circ. Res. 72, 187–193 (1993). [DOI] [PubMed] [Google Scholar]
  • 39.Kassab G. S., Fung Y. C., Topology and dimensions of pig coronary capillary network. Am. J. Physiol. 267, H319–H325 (1994). [DOI] [PubMed] [Google Scholar]
  • 40.Lanotte L., et al. , Red cells’ dynamic morphologies govern blood shear thinning under microcirculatory flow conditions. Proc. Natl. Acad. Sci. U.S.A. 113, 13289–13294 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Reichel F., et al. , High-throughput microfluidic characterization of erythrocyte shapes and mechanical variability. Biophys. J. 117, 14–24 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Skalak R., Branemark P. I., Deformation of red blood cells in capillaries. Science 164, 717–719 (1969). [DOI] [PubMed] [Google Scholar]
  • 43.Forsyth A. M., Wan J., Owrutsky P. D., Abkarian M., Stone H. A., Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release. Proc. Natl. Acad. Sci. U.S.A. 108, 10986–10991 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Fischer T. M., Stöhr-Lissen M., Schmid-Schönbein H., The red cell as a fluid droplet: Tank tread-like motion of the human erythrocyte membrane in shear flow. Science 202, 894–896 (1978). [DOI] [PubMed] [Google Scholar]
  • 45.Goldsmith H. L., The flow of model particles and blood cells and its relation to thrombogenesis. Prog. Hemost. Thromb. 1, 97–127 (1972). [PubMed] [Google Scholar]
  • 46.Dupire J., Socol M., Viallat A., Full dynamics of a red blood cell in shear flow. Proc. Natl. Acad. Sci. U.S.A. 109, 20808–20813 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Diez-Silva M., Dao M., Han J., Lim C. T., Suresh S., Shape and biomechanical characteristics of human red blood cells in health and disease. MRS Bull. 35, 382–388 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bolton-Maggs P. H., Langer J. C., Iolascon A., Tittensor P., King M. J.; General Haematology Task Force of the British Committee for Standards in Haematology , Guidelines for the diagnosis and management of hereditary spherocytosis–2011 update. Br. J. Haematol. 156, 37–49 (2012). [DOI] [PubMed] [Google Scholar]
  • 49.Iolascon A., et al. ; Working Study Group on Red Cells and Iron of the EHA , Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica 102, 1304–1313 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Casale M., Perrotta S., Splenectomy for hereditary spherocytosis: Complete, partial or not at all? Expert Rev. Hematol. 4, 627–635 (2011). [DOI] [PubMed] [Google Scholar]
  • 51.Reliene R., et al. , Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood 100, 2208–2215 (2002). [PubMed] [Google Scholar]
  • 52.Agre P., Asimos A., Casella J. F., McMillan C., Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N. Engl. J. Med. 315, 1579–1583 (1986). [DOI] [PubMed] [Google Scholar]
  • 53.Pincez T., et al. , Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: A single-center study. Blood 127, 1616–1618 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Tripodi S. I., Shamberger R. C., Heeney M. M., Tubman V. N., Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis. Pediatr. Hematol. Oncol. 36, 382–389 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Roussel C., et al. , Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion. Transfusion 57, 1007–1018 (2017). [DOI] [PubMed] [Google Scholar]
  • 56.Semenza G. L., Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551–578 (1999). [DOI] [PubMed] [Google Scholar]
  • 57.Hulikova A., Swietach P., Rapid CO2 permeation across biological membranes: Implications for CO2 venting from tissue. FASEB J. 28, 2762–2774 (2014). [DOI] [PubMed] [Google Scholar]
  • 58.Spitzer K. W., Bridge J. H., A simple device for rapidly exchanging solution surrounding a single cardiac cell. Am. J. Physiol. 256, C441–C447 (1989). [DOI] [PubMed] [Google Scholar]
  • 59.Swietach P., et al. , Hydrogen ion dynamics in human red blood cells. J. Physiol. 588, 4995–5014 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File

Data Availability Statement

All relevant data are included herein or in SI Appendix. All relevant clinical information concerning patient samples is given in SI Appendix, Table S1.


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES